Research ArticleCancer

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

See allHide authors and affiliations

Science Translational Medicine  19 Nov 2014:
Vol. 6, Issue 263, pp. 263ra161
DOI: 10.1126/scitranslmed.3010382

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article